Head-to-Head

Abbott Laboratories vs. Aktis Oncology, Inc. Common stock

ABT

Abbott Laboratories

$108.52 +1.18%

VS AKTS

Aktis Oncology, Inc. Common stock

$16.55 -0.45%

Abbott Laboratories (ABT) comes out ahead, leading on 2 of 2 compared factors.

Size & Scale

ABTAKTS
Market Cap $187.95 billion $927.36 million

ABT leads on 1 of 1 size & scale factors.

Dividend

ABTAKTS
Dividend Yield 2.32% —

ABT and AKTS split the dividend factors evenly.

Risk & Sentiment

ABTAKTS
Short Interest 0.57% 1.61%

ABT leads on 1 of 1 risk & sentiment factors.

Dig deeper: ABT overview, ABT financials, AKTS overview, AKTS financials.

Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.